Aeolus Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Fiscal Year	Current	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Jan '26 Jan 22, 2026	Sep '16 Sep 30, 2016	Sep '15 Sep 30, 2015	Sep '14 Sep 30, 2014	Sep '13 Sep 30, 2013	Sep '12 Sep 30, 2012
Market Capitalization	0	29	33	34	38	23
Market Cap Growth	-97.73%	-11.64%	-2.77%	-10.71%	62.31%	-8.61%
Enterprise Value	-	25	32	32	35	23
Last Close Price	0.00	0.19	0.24	0.25	0.28	0.37
PE Ratio	-	-	-	-	-	27.12
PS Ratio	0.02	13.92	10.51	3.49	9.59	3.18
PB Ratio	0.07	9.04	-38.70	21.22	53.44	-1.14
P/TBV Ratio	0.07	9.04	-	21.29	53.82	-
P/FCF Ratio	-	-	-	104.14	-	-
P/OCF Ratio	-	-	-	104.14	-	-
EV/Sales Ratio	-	12.11	10.38	3.36	8.90	3.16
EV/FCF Ratio	-	-	-	100.22	-	-
Debt / Equity Ratio	-	-	-1.19	-	-	-
Asset Turnover	0.27	0.70	1.16	3.47	2.44	4.11
Quick Ratio	1.22	4.02	0.64	1.54	0.98	0.47
Current Ratio	1.30	4.25	0.67	1.78	1.53	0.54
Return on Equity (ROE)	-186.43%	-302.81%	-710.27%	-6.99%	-	-
Return on Assets (ROA)	-90.30%	-68.83%	-61.27%	-1.80%	-104.67%	-83.58%
Return on Capital Employed (ROCE)	-1977.80%	-102.40%	310.80%	-5.00%	-382.70%	233.40%
Earnings Yield	-26918.27%	-12.31%	-8.04%	-0.24%	-8.52%	7.32%
FCF Yield	-	-10.76%	-7.47%	0.96%	-7.88%	-3.79%
Buyback Yield / Dilution	-5.16%	-9.41%	-0.90%	-26.38%	-49.99%	17.26%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.